HEADER VIRAL PROTEIN 31-JUL-24 9IYX TITLE STRUCTURE OF HBV SURFACE ANTIGEN DETERMINED IN RECOMBINANT SPHERICAL TITLE 2 SUBVIRAL PARTICLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LARGE ENVELOPE PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: L GLYCOPROTEIN,L-HBSAG,LHB,LARGE S PROTEIN,LARGE SURFACE COMPND 5 PROTEIN,MAJOR SURFACE ANTIGEN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HBV GENOTYPE D3; SOURCE 3 ORGANISM_COMMON: HBV; SOURCE 4 ORGANISM_TAXID: 1219353; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS HBV, HBSAG, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR L.CHEN,X.HE REVDAT 1 15-JAN-25 9IYX 0 JRNL AUTH X.HE JRNL TITL STRUCTURAL ASYMMETRY OF HBSAG DICTATES THE BINDING OF HBV JRNL TITL 2 NEUTRALIZATION ANTIBODIES JRNL REF CELL DISCOV 2025 JRNL REFN ESSN 2056-5968 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 159036 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9IYX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-AUG-24. REMARK 100 THE DEPOSITION ID IS D_1300049989. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HBV SURFACE ANTIGEN DIMER REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.41 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 GLN A 51 REMARK 465 ASN A 52 REMARK 465 SER A 53 REMARK 465 GLN A 54 REMARK 465 SER A 55 REMARK 465 PRO A 56 REMARK 465 PRO A 111 REMARK 465 GLY A 112 REMARK 465 SER A 113 REMARK 465 SER A 114 REMARK 465 THR A 115 REMARK 465 THR A 116 REMARK 465 SER A 117 REMARK 465 THR A 118 REMARK 465 GLY A 119 REMARK 465 PRO A 120 REMARK 465 CYS A 121 REMARK 465 ARG A 122 REMARK 465 THR A 123 REMARK 465 CYS A 124 REMARK 465 MET A 125 REMARK 465 THR A 126 REMARK 465 THR A 127 REMARK 465 ALA A 128 REMARK 465 GLN A 129 REMARK 465 GLY A 130 REMARK 465 THR A 131 REMARK 465 SER A 132 REMARK 465 MET A 133 REMARK 465 TYR A 134 REMARK 465 PRO A 135 REMARK 465 SER A 136 REMARK 465 CYS A 137 REMARK 465 CYS A 138 REMARK 465 CYS A 139 REMARK 465 THR A 140 REMARK 465 LYS A 141 REMARK 465 PRO A 142 REMARK 465 SER A 143 REMARK 465 ASP A 144 REMARK 465 GLY A 145 REMARK 465 ASN A 146 REMARK 465 CYS A 147 REMARK 465 THR A 148 REMARK 465 CYS A 149 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ASN B 3 REMARK 465 ILE B 4 REMARK 465 THR B 5 REMARK 465 SER B 6 REMARK 465 GLY B 7 REMARK 465 PHE B 8 REMARK 465 GLN B 51 REMARK 465 ASN B 52 REMARK 465 SER B 53 REMARK 465 GLN B 54 REMARK 465 SER B 55 REMARK 465 PRO B 56 REMARK 465 THR B 57 REMARK 465 PRO B 111 REMARK 465 GLY B 112 REMARK 465 SER B 113 REMARK 465 SER B 114 REMARK 465 THR B 115 REMARK 465 THR B 116 REMARK 465 SER B 117 REMARK 465 THR B 118 REMARK 465 GLY B 119 REMARK 465 PRO B 120 REMARK 465 CYS B 121 REMARK 465 ARG B 122 REMARK 465 THR B 123 REMARK 465 CYS B 124 REMARK 465 MET B 125 REMARK 465 THR B 126 REMARK 465 THR B 127 REMARK 465 ALA B 128 REMARK 465 GLN B 129 REMARK 465 GLY B 130 REMARK 465 THR B 131 REMARK 465 SER B 132 REMARK 465 MET B 133 REMARK 465 TYR B 134 REMARK 465 PRO B 135 REMARK 465 SER B 136 REMARK 465 CYS B 137 REMARK 465 CYS B 138 REMARK 465 CYS B 139 REMARK 465 THR B 140 REMARK 465 LYS B 141 REMARK 465 PRO B 142 REMARK 465 SER B 143 REMARK 465 ASP B 144 REMARK 465 GLY B 145 REMARK 465 ASN B 146 REMARK 465 CYS B 147 REMARK 465 THR B 148 REMARK 465 CYS B 149 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 3 CG OD1 ND2 REMARK 470 SER A 6 OG REMARK 470 LEU A 13 CG CD1 CD2 REMARK 470 THR A 57 OG1 CG2 REMARK 470 ASN A 59 CG OD1 ND2 REMARK 470 THR A 68 OG1 CG2 REMARK 470 PHE A 170 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 171 OG REMARK 470 TRP A 172 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 172 CZ3 CH2 REMARK 470 LEU A 173 CG CD1 CD2 REMARK 470 SER A 174 OG REMARK 470 LEU A 175 CG CD1 CD2 REMARK 470 LEU A 176 CG CD1 CD2 REMARK 470 VAL A 177 CG1 CG2 REMARK 470 VAL A 180 CG1 CG2 REMARK 470 GLN A 181 CG CD OE1 NE2 REMARK 470 PHE A 183 CG CD1 CD2 CE1 CE2 CZ REMARK 470 VAL A 184 CG1 CG2 REMARK 470 LEU A 186 CG CD1 CD2 REMARK 470 THR A 189 OG1 CG2 REMARK 470 VAL A 190 CG1 CG2 REMARK 470 TRP A 191 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 191 CZ3 CH2 REMARK 470 LEU A 192 CG CD1 CD2 REMARK 470 SER A 193 OG REMARK 470 VAL A 194 CG1 CG2 REMARK 470 MET A 197 CG SD CE REMARK 470 MET A 198 CG SD CE REMARK 470 TRP A 201 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 201 CZ3 CH2 REMARK 470 SER A 204 OG REMARK 470 LEU A 205 CG CD1 CD2 REMARK 470 SER A 207 OG REMARK 470 ILE A 208 CG1 CG2 CD1 REMARK 470 LEU A 209 CG CD1 CD2 REMARK 470 SER A 210 OG REMARK 470 PHE A 212 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 213 CG CD1 CD2 REMARK 470 LEU A 215 CG CD1 CD2 REMARK 470 LEU A 216 CG CD1 CD2 REMARK 470 PRO A 217 CG CD REMARK 470 PHE A 219 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE A 220 CG CD1 CD2 CE1 CE2 CZ REMARK 470 CYS A 221 SG REMARK 470 LEU A 222 CG CD1 CD2 REMARK 470 TRP A 223 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 223 CZ3 CH2 REMARK 470 VAL A 224 CG1 CG2 REMARK 470 TYR A 225 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 226 CG1 CG2 CD1 REMARK 470 LEU B 12 CG CD1 CD2 REMARK 470 GLN B 16 CG CD OE1 NE2 REMARK 470 TRP B 172 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 172 CZ3 CH2 REMARK 470 LEU B 173 CG CD1 CD2 REMARK 470 SER B 174 OG REMARK 470 LEU B 175 CG CD1 CD2 REMARK 470 LEU B 176 CG CD1 CD2 REMARK 470 VAL B 177 CG1 CG2 REMARK 470 PHE B 179 CG CD1 CD2 CE1 CE2 CZ REMARK 470 VAL B 180 CG1 CG2 REMARK 470 GLN B 181 CG CD OE1 NE2 REMARK 470 LEU B 186 CG CD1 CD2 REMARK 470 TRP B 191 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 191 CZ3 CH2 REMARK 470 LEU B 213 CG CD1 CD2 REMARK 470 LEU B 215 CG CD1 CD2 REMARK 470 LEU B 216 CG CD1 CD2 REMARK 470 PHE B 220 CG CD1 CD2 CE1 CE2 CZ REMARK 470 CYS B 221 SG REMARK 470 LEU B 222 CG CD1 CD2 REMARK 470 TRP B 223 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 223 CZ3 CH2 REMARK 470 VAL B 224 CG1 CG2 REMARK 470 TYR B 225 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TRP A 35 OG SER A 38 2.13 REMARK 500 OE1 GLN B 30 NH2 ARG B 79 2.14 REMARK 500 O TRP A 201 N LEU A 205 2.16 REMARK 500 O PRO A 62 NH2 ARG A 78 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 46 -161.99 66.06 REMARK 500 SER B 171 -5.28 74.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 48 SG REMARK 620 2 HIS A 60 NE2 127.7 REMARK 620 3 CYS A 65 SG 114.5 97.3 REMARK 620 4 CYS A 69 SG 110.6 94.1 110.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 48 SG REMARK 620 2 HIS B 60 NE2 121.1 REMARK 620 3 CYS B 65 SG 116.7 113.5 REMARK 620 4 CYS B 69 SG 111.0 67.2 118.0 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-61003 RELATED DB: EMDB REMARK 900 STRUCTURE OF HBV SURFACE ANTIGEN DETERMINED IN RECOMBINANT REMARK 900 SPHERICAL SUBVIRAL PARTICLE DBREF 9IYX A 1 226 UNP V9P415 V9P415_HBV 164 389 DBREF 9IYX B 1 226 UNP V9P415 V9P415_HBV 164 389 SEQRES 1 A 226 MET GLU ASN ILE THR SER GLY PHE LEU GLY PRO LEU LEU SEQRES 2 A 226 VAL LEU GLN ALA GLY PHE PHE LEU LEU THR ARG ILE LEU SEQRES 3 A 226 THR ILE PRO GLN SER LEU ASP SER TRP TRP THR SER LEU SEQRES 4 A 226 ASN PHE LEU GLY GLY THR THR VAL CYS LEU GLY GLN ASN SEQRES 5 A 226 SER GLN SER PRO THR SER ASN HIS SER PRO THR SER CYS SEQRES 6 A 226 PRO PRO THR CYS PRO GLY TYR ARG TRP MET CYS LEU ARG SEQRES 7 A 226 ARG PHE ILE ILE PHE LEU PHE ILE LEU LEU LEU CYS LEU SEQRES 8 A 226 ILE PHE LEU LEU VAL LEU LEU ASP TYR GLN GLY MET LEU SEQRES 9 A 226 PRO VAL CYS PRO LEU ILE PRO GLY SER SER THR THR SER SEQRES 10 A 226 THR GLY PRO CYS ARG THR CYS MET THR THR ALA GLN GLY SEQRES 11 A 226 THR SER MET TYR PRO SER CYS CYS CYS THR LYS PRO SER SEQRES 12 A 226 ASP GLY ASN CYS THR CYS ILE PRO ILE PRO SER SER TRP SEQRES 13 A 226 ALA PHE GLY LYS PHE LEU TRP GLU TRP ALA SER ALA ARG SEQRES 14 A 226 PHE SER TRP LEU SER LEU LEU VAL PRO PHE VAL GLN TRP SEQRES 15 A 226 PHE VAL GLY LEU SER PRO THR VAL TRP LEU SER VAL ILE SEQRES 16 A 226 TRP MET MET TRP TYR TRP GLY PRO SER LEU TYR SER ILE SEQRES 17 A 226 LEU SER PRO PHE LEU PRO LEU LEU PRO ILE PHE PHE CYS SEQRES 18 A 226 LEU TRP VAL TYR ILE SEQRES 1 B 226 MET GLU ASN ILE THR SER GLY PHE LEU GLY PRO LEU LEU SEQRES 2 B 226 VAL LEU GLN ALA GLY PHE PHE LEU LEU THR ARG ILE LEU SEQRES 3 B 226 THR ILE PRO GLN SER LEU ASP SER TRP TRP THR SER LEU SEQRES 4 B 226 ASN PHE LEU GLY GLY THR THR VAL CYS LEU GLY GLN ASN SEQRES 5 B 226 SER GLN SER PRO THR SER ASN HIS SER PRO THR SER CYS SEQRES 6 B 226 PRO PRO THR CYS PRO GLY TYR ARG TRP MET CYS LEU ARG SEQRES 7 B 226 ARG PHE ILE ILE PHE LEU PHE ILE LEU LEU LEU CYS LEU SEQRES 8 B 226 ILE PHE LEU LEU VAL LEU LEU ASP TYR GLN GLY MET LEU SEQRES 9 B 226 PRO VAL CYS PRO LEU ILE PRO GLY SER SER THR THR SER SEQRES 10 B 226 THR GLY PRO CYS ARG THR CYS MET THR THR ALA GLN GLY SEQRES 11 B 226 THR SER MET TYR PRO SER CYS CYS CYS THR LYS PRO SER SEQRES 12 B 226 ASP GLY ASN CYS THR CYS ILE PRO ILE PRO SER SER TRP SEQRES 13 B 226 ALA PHE GLY LYS PHE LEU TRP GLU TRP ALA SER ALA ARG SEQRES 14 B 226 PHE SER TRP LEU SER LEU LEU VAL PRO PHE VAL GLN TRP SEQRES 15 B 226 PHE VAL GLY LEU SER PRO THR VAL TRP LEU SER VAL ILE SEQRES 16 B 226 TRP MET MET TRP TYR TRP GLY PRO SER LEU TYR SER ILE SEQRES 17 B 226 LEU SER PRO PHE LEU PRO LEU LEU PRO ILE PHE PHE CYS SEQRES 18 B 226 LEU TRP VAL TYR ILE HET ZN A1001 1 HET ZN B 301 1 HETNAM ZN ZINC ION FORMUL 3 ZN 2(ZN 2+) HELIX 1 AA1 ASN A 3 LEU A 26 1 24 HELIX 2 AA2 THR A 27 PHE A 41 1 15 HELIX 3 AA3 PRO A 70 ASP A 99 1 30 HELIX 4 AA4 TYR A 100 GLY A 102 5 3 HELIX 5 AA5 TRP A 156 PHE A 170 1 15 HELIX 6 AA6 PHE A 170 LEU A 186 1 17 HELIX 7 AA7 SER A 187 SER A 207 1 21 HELIX 8 AA8 ILE A 208 SER A 210 5 3 HELIX 9 AA9 PRO A 211 ILE A 226 1 16 HELIX 10 AB1 GLY B 10 PHE B 41 1 32 HELIX 11 AB2 CYS B 69 GLY B 102 1 34 HELIX 12 AB3 TRP B 156 SER B 171 1 16 HELIX 13 AB4 TRP B 172 LEU B 186 1 15 HELIX 14 AB5 THR B 189 SER B 210 1 22 HELIX 15 AB6 PRO B 211 LEU B 213 5 3 HELIX 16 AB7 PRO B 214 ILE B 226 1 13 LINK SG CYS A 48 ZN ZN A1001 1555 1555 2.32 LINK NE2 HIS A 60 ZN ZN A1001 1555 1555 2.05 LINK SG CYS A 65 ZN ZN A1001 1555 1555 2.32 LINK SG CYS A 69 ZN ZN A1001 1555 1555 2.31 LINK SG CYS B 48 ZN ZN B 301 1555 1555 2.32 LINK NE2 HIS B 60 ZN ZN B 301 1555 1555 2.04 LINK SG CYS B 65 ZN ZN B 301 1555 1555 2.33 LINK SG CYS B 69 ZN ZN B 301 1555 1555 2.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000